Citation 89051

WATANABE,K: MIMAKI,Y: SAKAGAMI,H: SASHIDA,Y:. (2003). BUFADIENOLIDE AND SPIROSTANOL GLYCOSIDES FROM THE RHIZOMES OF HELLEBORUS ORIENTALIS.. 66(2)

Citation Details

Title	BUFADIENOLIDE AND SPIROSTANOL GLYCOSIDES FROM THE RHIZOMES OF HELLEBORUS ORIENTALIS.
Authors	WATANABE,K: MIMAKI,Y: SAKAGAMI,H: SASHIDA,Y:
Year	2003
Volume	66
Issue	2

Summary

Year: 2003

Journal: Unknown

Organisms and Their Experiments (1)

Helleborus orientalis (RANUNCULACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	VOUCHER SPECIMEN REPORTED FOR	None	None
2	Not specified	PMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	BUFA-20-22-DIENOLIDE,5-BETA-14-BETA-16-BETA-TRIHYDROXY-19-OXO-3-BETA-[(ALPHA-L-RHAMNOPYRANOSYL)-OXY]:	None
3	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BUFA-20-22-DIENOLIDE,5-BETA-14-BETA-16-BETA-TRIHYDROXY-19-OXO-3-BETA-[(ALPHA-L-RHAMNOPYRANOSYL)-OXY]:	STRONG ACTIVITY
4	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BUFA-20-22-DIENOLIDE,5-BETA-14-BETA-16-BETA-TRIHYDROXY-19-OXO-3-BETA-[(ALPHA-L-RHAMNOPYRANOSYL)-OXY]:	STRONG ACTIVITY
5	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BUFA-20-22-DIENOLIDE,5-BETA-14-BETA-16-BETA-TRIHYDROXY-19-OXO-3-BETA-[(ALPHA-L-RHAMNOPYRANOSYL)-OXY]:	STRONG ACTIVITY
6	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BUFA-20-22-DIENOLIDE,5-BETA-14-BETA-16-BETA-TRIHYDROXY-19-OXO-3-BETA-[(ALPHA-L-RHAMNOPYRANOSYL)-OXY]:	WEAK ACTIVITY
7	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	BUFA-20-22-DIENOLIDE,5-BETA-14-BETA-DIHYDROXY-19-OXO-3-BETA-[(ALPHA-L-RHAMNOPYRANOSYL)-OXY]:	None
8	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BUFA-20-22-DIENOLIDE,5-BETA-14-BETA-DIHYDROXY-19-OXO-3-BETA-[(ALPHA-L-RHAMNOPYRANOSYL)-OXY]:	STRONG ACTIVITY
9	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BUFA-20-22-DIENOLIDE,5-BETA-14-BETA-DIHYDROXY-19-OXO-3-BETA-[(ALPHA-L-RHAMNOPYRANOSYL)-OXY]:	STRONG ACTIVITY
10	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BUFA-20-22-DIENOLIDE,5-BETA-14-BETA-DIHYDROXY-19-OXO-3-BETA-[(ALPHA-L-RHAMNOPYRANOSYL)-OXY]:	STRONG ACTIVITY
11	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BUFA-20-22-DIENOLIDE,5-BETA-14-BETA-DIHYDROXY-19-OXO-3-BETA-[(ALPHA-L-RHAMNOPYRANOSYL)-OXY]:	WEAK ACTIVITY
12	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	BUFA-20-22-DIENOLIDE,5-BETA-14-BETA-DIHYDROXY-19-OXO-3-BETA-[(BETA-D-GLUCOPYRANOSYL)-OXY]:	None
13	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BUFA-20-22-DIENOLIDE,5-BETA-14-BETA-DIHYDROXY-19-OXO-3-BETA-[(BETA-D-GLUCOPYRANOSYL)-OXY]:	STRONG ACTIVITY
14	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BUFA-20-22-DIENOLIDE,5-BETA-14-BETA-DIHYDROXY-19-OXO-3-BETA-[(BETA-D-GLUCOPYRANOSYL)-OXY]:	STRONG ACTIVITY
15	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BUFA-20-22-DIENOLIDE,5-BETA-14-BETA-DIHYDROXY-19-OXO-3-BETA-[(BETA-D-GLUCOPYRANOSYL)-OXY]:	STRONG ACTIVITY
16	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BUFA-20-22-DIENOLIDE,5-BETA-14-BETA-DIHYDROXY-19-OXO-3-BETA-[(BETA-D-GLUCOPYRANOSYL)-OXY]:	STRONG ACTIVITY
17	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	SPIROSTA-5-25(27)-DIEN-1-BETA-YL,3-BETA-23(S)-DIHYDROXY: O-BETA-D-APIOFURANOSYL(1-3)-O-(4-O-ACETYL-ALPHA-L-RHAMNOPYRANOSYL)-(1-2)-O-[BETA-D-XYLOPYRANOSYL(1-3)]-ALPHA-L-ARABINOPYRANOSIDE	None
18	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SPIROSTA-5-25(27)-DIEN-1-BETA-YL,3-BETA-23(S)-DIHYDROXY: O-BETA-D-APIOFURANOSYL(1-3)-O-(4-O-ACETYL-ALPHA-L-RHAMNOPYRANOSYL)-(1-2)-O-[BETA-D-XYLOPYRANOSYL(1-3)]-ALPHA-L-ARABINOPYRANOSIDE	EQUIVOCAL
19	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	SPIROSTA-5-25(27)-DIEN-1-BETA-YL,3-BETA-23(S)-24(S)-TRIHYDROXY: O-BETA-D-APIOFURANAOSYL(1-3)-O-(4-O-ACETYL-ALPHA-L-RHAMNOPYRANOSYL)-(1-2)-O-[BETA-D-XYLOPYRANOSYL(1-3)]-ALPHA-L-ARABINOPYRANOSIDE	None
20	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SPIROSTA-5-25(27)-DIEN-1-BETA-YL,3-BETA-23(S)-24(S)-TRIHYDROXY: O-BETA-D-APIOFURANAOSYL(1-3)-O-(4-O-ACETYL-ALPHA-L-RHAMNOPYRANOSYL)-(1-2)-O-[BETA-D-XYLOPYRANOSYL(1-3)]-ALPHA-L-ARABINOPYRANOSIDE	EQUIVOCAL
21	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	SPIROSTA-5-25(27)-DIEN-1-BETA-YL,21-ACETOXY-3-BETA-23(S)-24(S)-TRIHYDROXY: O-BETA-D-APIOFURANOSYL(1-3)-O-(4-O-ACETYL-ALPHA-L-RHAMNOPYRANOSYL)-(1-2)-O-[BETA-D-XYLOPYRANOSYL(1-3)]-ALPHA-L-ARABINOPYRANOSIDE	None
22	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SPIROSTA-5-25(27)-DIEN-1-BETA-YL,21-ACETOXY-3-BETA-23(S)-24(S)-TRIHYDROXY: O-BETA-D-APIOFURANOSYL(1-3)-O-(4-O-ACETYL-ALPHA-L-RHAMNOPYRANOSYL)-(1-2)-O-[BETA-D-XYLOPYRANOSYL(1-3)]-ALPHA-L-ARABINOPYRANOSIDE	INACTIVE
23	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	SPIROSTA-5-25(27)-DIEN-1-BETA-YL,21-ACETOXY-24(S)-[(O-BETA-D-GLUCOPYRANOSYL)-OXY]-3-BETA-23(S)-DIHYDROXY: O-BETA-D-APIOFURANOSYL(1-3)-O-(4-O-ACETYL-ALPHA-L-RHAMNOPYRANOSYL)-(1-2)-O-[BETA-D-XYLOPYRANOSYL(1-3)]-ALPHA-L-ARABINOPYRANOSIDE	None
24	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SPIROSTA-5-25(27)-DIEN-1-BETA-YL,21-ACETOXY-24(S)-[(O-BETA-D-GLUCOPYRANOSYL)-OXY]-3-BETA-23(S)-DIHYDROXY: O-BETA-D-APIOFURANOSYL(1-3)-O-(4-O-ACETYL-ALPHA-L-RHAMNOPYRANOSYL)-(1-2)-O-[BETA-D-XYLOPYRANOSYL(1-3)]-ALPHA-L-ARABINOPYRANOSIDE	INACTIVE
25	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	SPIROSTA-5-25(27)-DIEN-1-BETA-YL,21-ACETOXY-3-BETA-23(S)-DIHYDROXY-249S)-[(O-BETA-D-QUINOVOPYRANOSYL)-OXY]: O-BETA-D-APIOFURANOSYL(1-3)-O-(4-O-ACETYL-ALPHA-L-RHAMNOPYRANOSYL)-(1-2)-O-[BETA-D-XYLOPYRANOSYL(1-3)]-ALPHA-L-ARABINOPYRANOSIDE	None
26	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SPIROSTA-5-25(27)-DIEN-1-BETA-YL,21-ACETOXY-3-BETA-23(S)-DIHYDROXY-249S)-[(O-BETA-D-QUINOVOPYRANOSYL)-OXY]: O-BETA-D-APIOFURANOSYL(1-3)-O-(4-O-ACETYL-ALPHA-L-RHAMNOPYRANOSYL)-(1-2)-O-[BETA-D-XYLOPYRANOSYL(1-3)]-ALPHA-L-ARABINOPYRANOSIDE	INACTIVE

Citation 89051

Citation Details

Summary

Organisms and Their Experiments (1)

Helleborus orientalis (RANUNCULACEAE)

Show SPARQL Queries (1)

Query 1